ConductScience.org, home
The DNA damage response and cancer therapy.
API referenceFor AI assistants

Paper · 22258607

References71

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

1 to 20 of 71

Download this page as JSON
OrderPMIDTitleJournalYearIn PapersSource
19,353,181Integrating genetic approaches into the discovery of anticancer drugs.Science1997https://conductscience.org/library/papers/9353181PubMed
221,376,230Hallmarks of cancer: the next generation.Cell2011https://conductscience.org/library/papers/21376230PubMed
321,575,865Mechanistic rationale for inhibition of poly(ADP-ribose) polymerase in ETS gene fusion-positive prostate cancer.Cancer Cell2011https://conductscience.org/library/papers/21575865PubMed
415,829,967Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy.Nature2005https://conductscience.org/library/papers/15829967PubMed
55,683,639Synthetic lethality and semi-lethality among functionally related mutants of Drosophila melanfgaster.Genetics1968https://conductscience.org/library/papers/5683639PubMed
619,809,470Disorders of nucleotide excision repair: the genetic and molecular basis of heterogeneity.Nat Rev Genet2009https://conductscience.org/library/papers/19809470PubMed
77,669,074Potential chemotherapeutic activity of 4-iodo-3-nitrobenzamide. Metabolic reduction to the 3-nitroso derivative and induction of cell death in tumor cells in culture.Biochem Pharmacol1995https://conductscience.org/library/papers/7669074PubMed
820,700,108Making the best of PARP inhibitors in ovarian cancer.Nat Rev Clin Oncol2010https://conductscience.org/library/papers/20700108PubMed
920,368,722NHEJ and its backup pathways in chromosomal translocations.Nat Struct Mol Biol2010https://conductscience.org/library/papers/20368722PubMed
1019,654,294Functional restoration of BRCA2 protein by secondary BRCA2 mutations in BRCA2-mutated ovarian carcinoma.Cancer Res2009https://conductscience.org/library/papers/19654294PubMed
1119,997,073MGMT promoter methylation in malignant gliomas: ready for personalized medicine?Nat Rev Neurol2010https://conductscience.org/library/papers/19997073PubMed
1217,051,156Glioma stem cells promote radioresistance by preferential activation of the DNA damage response.Nature2006https://conductscience.org/library/papers/17051156PubMed
1321,195,000miR-182-mediated downregulation of BRCA1 impacts DNA repair and sensitivity to PARP inhibitors.Mol Cell2011https://conductscience.org/library/papers/21195000PubMed
1420,200,537PARP inhibition: PARP1 and beyond.Nat Rev Cancer2010https://conductscience.org/library/papers/20200537PubMed
1520,177,395Mitotic homologous recombination maintains genomic stability and suppresses tumorigenesis.Nat Rev Mol Cell Biol2010https://conductscience.org/library/papers/20177395PubMed
1620,534,341DNA topoisomerases and their poisoning by anticancer and antibacterial drugs.Chem Biol2010https://conductscience.org/library/papers/20534341PubMed
1720,033,038Complex landscapes of somatic rearrangement in human breast cancer genomes.Nature2009https://conductscience.org/library/papers/20033038PubMed
1820,631,0636-thioguanine selectively kills BRCA2-defective tumors and overcomes PARP inhibitor resistance.Cancer Res2010https://conductscience.org/library/papers/20631063PubMed
1921,709,188Secondary somatic mutations restoring BRCA1/2 predict chemotherapy resistance in hereditary ovarian carcinomas.J Clin Oncol2011https://conductscience.org/library/papers/21709188PubMed
203,205,307Correlation of DNA adduct levels in human lung with cigarette smoking.Nature1988https://conductscience.org/library/papers/3205307PubMed

papers-2026-11-12-0.1.0

Next page

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/papers/v1/22258607/references

API referenceFor AI assistants